Skip to content

Metacognitive therapy in schizophrenia

Efficacy of metacognitive therapy in reducing cognitive distortions in schizophrenia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011838
Enrollment
50
Registered
2018-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Schizophrenia

Interventions

Intervention1: Metacognitive therapy: The MCT group will be administered MCT as a group intervention twice weekly for 4 weeks( total of 8 sessions). Each Session will last for 45 to 60 minutes. The se

Sponsors

Central Institute of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as schizophrenia according ICD-10/DCR criteria. Minimum level of 8 years of education. Patients who will be willing to give informed consent for participation.

Exclusion criteria

Exclusion criteria: Major medical illness or neurological illness. History of substance or alcohol dependence except nicotine. Patients with other major psychiatric disorder.

Design outcomes

Primary

MeasureTime frame
cognitive distortions like attribution biases, jumping to conclusion.Timepoint: Base line, 4 weeks, 6 weeks, 10 weeks, 18 weeks

Secondary

MeasureTime frame
Theory of mind functioning, PSYRATS(Psychotic Symptom Rating Scales), PANSS,CGI(Clinical Global Improvement),RSES (Rosenberg Self Esteem Scale)Timepoint: Base line, 4 weeks, 6 weeks, 10 weeks, 18 weeks.

Countries

India

Contacts

Public ContactDr CRJ Khess

Department of Psychiatry

jmou@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026